ArticleAMB Express2025
Anti-aflatoxigenic effect of Lactobacillus rhamnosus and its synbiotic combination of chitosan/ZnO in milk.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Detoxification of aflatoxin MScientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aflatoxin contamination of milk is a serious health concern. When animals ingested food contaminated with aflatoxin B1 (AFB1), it would be converted into aflatoxin M1 (AFM1) and secreted in the milk. This carcinogenic and hepatotoxic toxin could be overcome by biological methods. Therefore, this study aimed to assess the anti-aflatoxigenic effect of the probiotic Lactobacillus rhamnosus (L. rhamnosus) ATCC 7469, as well as its synbiotic combination with chitosan ZnO nanocomposite using ELISA. This is carried out by measuring AFM1 concentration in 90 milk samples, including 73 raw and 27 powdered milk samples. The average AFM1 concentration was 11.22 ± 11.31 and 10.62 ± 8.08 µg/kg, which exceeded the international regulatory limits for raw and powdered milk, respectively. All milk samples were treated with L. rhamnosus ATCC 7469 and a synbiotic combination of chitosan/ZnO nanocomposite and L. rhamnosus ATCC 7469. The results showed that the probiotic L. rhamnosus ATCC 7469, and the synbiotic combination significantly reduced the AFM1 concentration in milk (p value ≤ 0.05). The used probiotic bacteria showed binding to AFM1 from 10 to 83.8%, while the binding range increased to 34-92% after treating milk with the synbiotic combination. In conclusion, the biological treatment of milk using the probiotic, L. rhamnosus ATCC 7469, alone or in combination with chitosan/ZnO nanocomposite, is an efficient method for reducing the AFM1 concentration in milk. This study highlights the use of both metal nanoparticles (as a prebiotic) and probiotics, forming a synbiotic approach to control milk contamination with aflatoxins in the laboratory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.